HOUSTON ― The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice president and chief wellness officer (CWO). She will begin on January 6, 2025. Working closely with the senior vice president of people, culture and infrastructure, as well as the chief academic officer, she will spearhead initiatives that prioritize employee well-being, professional fulfillment and community resilience. 

Pennington Biomedical Research Center researchers are gearing up and preparing to head to San Antonio for ObesityWeek 2024, presented by The Obesity Society. Pennington Biomedical will be well represented at the conference, as faculty members are not just participating in, but leading courses, presentations and speaker panels during the event. 

Pre-surgery treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab led to tumor control in 55% of patients with stage 3 cutaneous melanoma, according to the results of a single-arm phase 2 clinical trial led by the University of Pittsburgh, UPMC Hillman Cancer Center and the National Cancer Institute (NCI).

International oncology experts gather in Accra, Ghana for a series of meetings to update cancer treatment recommendations in the NCCN Harmonized Guidelines™ for Sub-Saharan Africa.

Leaders from the National Comprehensive Cancer Network (NCCN) travel to Vietnam to collaborate with Vietnam National Cancer Hospital on improving cancer care standards throughout the country.